Use of 15-valent pneumococcal conjugate vaccine and 20-valent pneumococcal conjugate vaccine among U.S. Adults: Updated recommendations of the Advisory Committee on Immunization Practices - United States, 2022
Open accessThe DOI matches its Crossref record; 28 of the 30 references it cites were found in a registry or an index.
Abstract
approach to guide its deliberations regarding use of these vaccines. Before this, PCV13 and PPSV23 were recommended for use for U.S. adults and the recommendations varied by age and risk groups. This was simplified in the new recommendations.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Overall, there is no evidence that incretin-based therapies increase risk for medullary thyroid carcinoma in humans.”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [1812]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“meta-analyses have not uncovered increased risk for thyroid cancer with GLP-1 RAs or DPP-4 inhibitors.”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [1812]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(2013) · American Journal of Transplantation · doi:10.1111/ajt.12073 · Cited by 687
Matanock, A., Lee, G., Gierke, R., Kobayashi, M., Leidner, A., & Pilishvili, T. (2019) · MMWR. Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6846a5 · Cited by 668 · cited 2×
“These adults should complete the previously recommended PPSV23††††† series (2,30).”
BackgroundSelf-citationNuorti, J. P., & Whitney, C. G. (2010) · MMWR Morbidity and Mortality Weekly Report · Cited by 456
Kobayashi, M., Bennett, N. M., Gierke, R., Almendares, O., Moore, M. R., Whitney, C. G., & Pilishvili, T. (2015) · MMWR. Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6434a4 · Cited by 219 · cited 1×
“A minimum interval of 8 weeks can be considered for adults with an immunocompromising condition, cochlear implant, or cerebrospinal fluid leak to minimize the risk for IPD caused by serotypes unique to PPSV23 in these vulnerable groups (31).”
BackgroundSelf-citationSuzuki, M., Dhoubhadel, B. G., Ishifuji, T., Yasunami, M., Yaegashi, M., Asoh, N., Ishida, M., Hamaguchi, S., Aoshima, M., Ariyoshi, K., et al. (2017) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(17)30049-x · Cited by 178
Jackson, L. A., Gurtman, A., van Cleeff, M., Frenck, R. W., Treanor, J., Jansen, K. U., Scott, D. A., Emini, E. A., Gruber, W. C., & Schmoele-Thoma, B. (2013) · Vaccine · doi:10.1016/j.vaccine.2013.04.084 · Cited by 165
Greenberg, R. N., Gurtman, A., Frenck, R. W., Strout, C., Jansen, K. U., Trammel, J., Scott, D. A., Emini, E. A., Gruber, W. C., & Schmoele-Thoma, B. (2014) · Vaccine · doi:10.1016/j.vaccine.2014.02.002 · Cited by 163 · cited 1×
“In a study that compared antibody responses to 1 dose of PCV13 with responses to PCV13 followed by PPSV23 1 year apart, the immune responses following PPSV23 were significantly lower compared with the responses after a dose of PCV13 for eight of 12 common serotypes (27).”
ResultHurley, D., Griffin, C., Young, M. M., Scott, D. A., Pride, M. W., Scully, I. L., Ginis, J., Severs, J. M., Jansen, K. U., Gruber, W. C., et al. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa1045 · Cited by 156 · cited 1×
“Compared with PPSV23 recipients, PCV20 recipients had numerically higher GMTs and a higher percentage of seroresponders to six of seven (excluding serotype 8) shared non-PCV13 serotypes (21,23); noninferiority criteria were met for those six serotypes (21).”
Background
Cited by
Blonde, L., Umpierrez, G. E., Reddy, S. S., McGill, J. B., Berga, S. L., Bush, M., Chandrasekaran, S., DeFronzo, R. A., Einhorn, D., Galindo, R. J., et al. (2022) · Endocrine Practice · doi:10.1016/j.eprac.2022.08.002 · Cited by 507
Bruner, L. P., White, A. M., & Proksell, S. (2023) · Primary Care: Clinics in Office Practice · doi:10.1016/j.pop.2023.03.009 · Cited by 271
Bass, A. R., Chakravarty, E., Akl, E. A., Bingham, C. O., Calabrese, L., Cappelli, L. C., Johnson, S. R., Imundo, L. F., Winthrop, K. L., Arasaratnam, R. J., et al. (2023) · Arthritis Care & Research · doi:10.1002/acr.25045 · Cited by 229
ElSayed, N. A., Aleppo, G., Aroda, V. R., Bannuru, R. R., Brown, F. M., Bruemmer, D., Collins, B. S., Cusi, K., Hilliard, M. E., Isaacs, D., et al. (2023) · Diabetes Care · doi:10.2337/dc23-s004 · Cited by 222
ElSayed, N. A., Aleppo, G., Bannuru, R. R., Bruemmer, D., Collins, B. S., Cusi, K. J., Ekhlaspour, L., Fleming, T. K., Hilliard, M. E., Johnson, E. L., et al. (2023) · Diabetes Care · doi:10.2337/dc24-s004 · Cited by 250
Metadata
- Authors
- Kobayashi, M., Farrar, J. L., Gierke, R., Britton, A., Childs, L., Leidner, A. J., Campos-Outcalt, D., Morgan, R. L., Long, S. S., Talbot, H. K., Poehling, K. A., & Pilishvili, T.
- Affiliations
- National Center for Immunization and Respiratory Diseases (US)
- Centers for Disease Control and Prevention (US)
- CDC Foundation (US)
- Center for Surveillance, Epidemiology, and Laboratory Services (US)
- University of Arizona (US)
- Corresponding author
- Kobayashi, Miwako
- ORCID
- Venue
- MMWR. Morbidity and Mortality Weekly Report
- Published
- 2022-01-28
- Volume
- 71
- Issue
- 4
- Pages
- 109-117
- ISSN
- 0149-2195 (ISSN-L)
- 1545-861X
- PMC
- PMC9351524
- OpenAlex
- W4210247696
- Cited by
- 352
- References
- 30
- Citations by year
- 2026: 36 · 2025: 58 · 2024: 79 · 2023: 115 · 2022: 64
- FWCI
- 57.03
- Type
- journal article
- Language
- en
- Open access
- diamond
- doi.org
- Locations
- MMWR Morbidity and Mortality Weekly Report (publishedVersion)
- PubMed Central (publishedVersion, public-domain)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Epidemiology › Pneumonia and Respiratory Infections
- Life Sciences › Immunology and Microbiology › Microbiology › Bacterial Infections and Vaccines
- Life Sciences › Immunology and Microbiology › Microbiology › Microbial infections and disease research
- Keywords
- PCV15, PCV20, pneumococcal vaccination, adults, Advisory Committee on Immunization Practices recommendations, Streptococcus pneumoniae, vaccine recommendations, risk groups
- MeSH terms
- GRADE Approach, Adult, Aged, Centers for Disease Control and Prevention, U.S., Health Planning Guidelines, Humans, Middle Aged, United States, Vaccines, Conjugate, Pneumococcal Vaccines, Advisory Committees
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Use of 15-valent pneumococcal conjugate vaccine and 20-valent pneumococcal conjugate vaccine among U.S. Adults: Updated recommendations of the Advisory Committee on Immunization Practices - United States, 2022. https://app.cochat.ai/papers/10.15585/mmwr.mm7104a1
- The paper
- Kobayashi, M., Farrar, J. L., Gierke, R., Britton, A., Childs, L., Leidner, A. J., Campos-Outcalt, D., Morgan, R. L., Long, S. S., Talbot, H. K., Poehling, K. A., & Pilishvili, T. (2022). Use of 15-valent pneumococcal conjugate vaccine and 20-valent pneumococcal conjugate vaccine among U.S. Adults: Updated recommendations of the Advisory Committee on Immunization Practices - United States, 2022. MMWR. Morbidity and Mortality Weekly Report. https://doi.org/10.15585/mmwr.mm7104a1
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.